Extended Data Fig. 9: Association between with clinical outcome and cell proliferation metrics.
From: Temporal and spatial topography of cell proliferation in cancer
a. Scatter plots of CFD versus IOV from mesothelioma and glioblastoma sample cohorts (n = 22 and 32 patients, respectively). Colors represent binning into coherence groups according IOV and CFD metrics. b-c. Kaplan Meier estimation and logrank p-value of progression-free survival (PFS) for the two patient cohorts in Fig. 7. Patients were binned in b. three groups “coherent”, IOVhigh “skewed” and IOVlow CFDhigh “non-canonical” groups from panel a). or c. two groups based on the median Ki-67+ fraction.
